Cassava is stopping all development of simufilam in Alzheimer’s disease. Image credit: Shutterstock / Mikadun. Cassava Sciences has officially stopped the development of its investigational drug ...

Dr Siboniso Moyo, the Deputy Director Partnership and Impact at the International Livestock Research Institute (ILRI) in this interview with KAZEEM AWOJOODU shared about the Livestock Master Plan (LMP ...

Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era defined by controversy and failed clinical trials. The company reported the ...

Cassava Technologies has announced plans to construct Africa’s first AI factory, a state-of-the-art data center facility equipped with NVIDIA’s advanced AI computing technology. The initiative aims to ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

Cassava Technologies has tapped Nvidia to build Africa’s first artificial intelligence "factory". Cassava Technologies, founded by Zimbabwean telecommunications tycoon Strive Masiyiwa, has tapped ...

Cassava Technologies has announced plans to build Africa’s first “AI Factory” — a high-performance, AI-enabled data center powered by NVIDIA’s advanced computing technology. At the ...

Kiwi fruit's peel, often discarded, is rich in fibre, antioxidants, and polyphenols. Eating the entire kiwi, including the skin, enhances gut health and supports weight management due to its high ...

Global technology firm, Cassava Technologies, will partner American multinational corporation and technology company, Nvidia Corporation, to build Africa’s first artificial intelligence (AI ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease Simufilam continued to ...